A new study led by researchers at the UCLA Health Jonsson ... evaluated with advanced prostate-specific membrane antigen-positron emission tomography (PSMA-PET) imaging, suggesting that ...

of UCLA Health in Los Angeles, and co-authors in JAMA Network Open. "PSMA-PET/CT continues to evolve as the most accurate imaging method for staging prostate cancer. Our results underline this is ...

A new study led by researchers at the UCLA Health Jonsson ... evaluated with advanced prostate-specific membrane antigen–positron emission tomography (PSMA-PET) imaging, suggesting that ...

PSMA PET scans, for instance, enable precise detection of prostate cancer even in its earliest stages ... significantly ...

These services include specialized options tailored to various cancer types. The PSMA PET CT scan is designed for prostate ...

A new UCLA Health Jonsson Comprehensive Cancer Center-led study has revealed that advanced prostate-specific membrane antigen positron emission tomography (PSMA-PET) imaging could reveal ...

Daniel Oguna, a PET CT technologist prepares a patient for a scan procedure at Aga Khan University Hospital, Nairobi. [Photo: Standard] The latest and most advanced scan for evaluation of patients ...

While prostate cancer is becoming more prevalent among middle-aged and elderly men in China, clinical practice still faces considerable challenges due to the lack of unified guidelines and high-level ...

This milestone builds on Clarity's earlier receipt of an FTD for 64 Cu-SAR-bisPSMA in patients with suspected metastasis of prostate cancer who are candidates for initial definitive therapy [1]. These ...

Telix Pharma’s prostate cancer PET1 imaging agent, Illuccix receives European marketing approval: Melbourne, Australia Saturday, January 18, 2025, 10:00 Hrs [IST] Telix Pharmace ...

PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...